 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 03, 2021 GLOBE NEWSWIRE -- ORIC Pharmaceuticals, Inc. Nasdaq: ORIC, a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in the following investor conferences in February: 